BICYCLE THERAPEUTICS PLC·4

Nov 13, 7:43 PM ET

Thompson Travis Alvin 4

4 · BICYCLE THERAPEUTICS PLC · Filed Nov 13, 2024

Insider Transaction Report

Form 4
Period: 2024-11-11
Thompson Travis Alvin
Chief Financial Officer
Transactions
  • Sale

    Ordinary Shares

    2024-11-11$24.77/sh209$5,17719,472 total
  • Exercise/Conversion

    Ordinary Shares

    2024-11-11$8.21/sh+154$1,26423,076 total
  • Sale

    Ordinary Shares

    2024-11-11$25.05/sh1,312$32,86622,922 total
  • Sale

    Ordinary Shares

    2024-11-11$25.01/sh154$3,85222,922 total
  • Exercise/Conversion

    Ordinary Shares

    2024-11-11$9.82/sh+1,109$10,89024,031 total
  • Sale

    Ordinary Shares

    2024-11-11$25.05/sh1,109$27,78022,922 total
  • Sale

    Ordinary Shares

    2024-11-11$25.21/sh3,241$81,70619,681 total
  • Exercise/Conversion

    Ordinary Shares

    2024-11-11$1.87/sh+1,312$2,45324,234 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-11-11154302 total
    Exercise: $8.21Exp: 2029-04-24Ordinary Shares (154 underlying)
  • Sale

    Ordinary Shares

    2024-11-11$24.82/sh231$5,73319,241 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-11-111,10912,954 total
    Exercise: $9.82Exp: 2029-04-24Ordinary Shares (1,109 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-11-111,3122,617 total
    Exercise: $1.87Exp: 2028-09-17Ordinary Shares (1,312 underlying)
Footnotes (7)
  • [F1]This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024.
  • [F2]This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6).
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.08 inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.81 inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $24.825 inclusive.
  • [F7]This option is fully vested and exercisable.

Documents

1 file
  • 4
    form4-11142024_121158.xmlPrimary